BPH Treatment Device Market Size, Share & COVID-19 Impact Analysis - Global - 2022-2028 - MedCore

BPH Treatment Device Market Size, Share & COVID-19 Impact Analysis - Global - 2022-2028 - MedCore

The total global BPH treatment device market is growing at a rate of 5.2%, which will take the 2021 market value of $1.2 billion up to $1.7 billion by 2028. The primary limiter of the BPH treatment device market is the increasing use of pharmaceutical treatments. In 2021, over 90% of BPH patients received drug therapy treatment over interventional methods.

The full report suite on the global market for benign prostatic hyperplasia (BPH) treatment devices includes transurethral resection of the prostate (TURP), laser BPH, UroLift® and Rezum® segments. The TURP market is further segmented into monopolar and bipolar electrodes. The laser BPH market includes high-power Holmium equipment and dedicated fiber, as well as thulium equipment and fiber segments. The UroLift® and Rezum® markets are defined by consumables required for each of the procedure.

MARKET REPORT DATA TYPES INCLUDED

• Procedure Numbers, Unit Sales, Average Selling Prices, Market Value & Growth Trends
• COVID-19 Impact Analysis
• 10 Year Scope and Forecast Range
• Market Drivers & Limiters for Each Segment
• Competitive Analysis with Market Shares for Each Segment
• Recent Mergers & Acquisitions
• Disease Overviews and Demographic Information
• Company Profiles and SWOT for Top Competitors

GLOBAL BPH TREATMENT DEVICE MARKET TRENDS

Both Rezūm® and Urolift® are relatively new treatments for BPH. They are both non-invasive procedures that are being adopted primarily in developed countries such as United States and in Western Europe. These markets are relatively new and many countries have not yet adopted these technologies. As countries begin reimbursing for these treatments, the market will grow significantly.

GLOBAL BPH TREATMENT DEVICE MARKET SHARE INSIGHTS

Overall, within the global BPH treatment device market there are three dominant competitors: Boston Scientific, Teleflex, and Olympus. In 2021, the leading competitor in the BPH treatment device market was Boston Scientific. The company held the dominant leading position in the laser BPH market and a monopolistic position in the Rezūm® market. The company held the second-leading share in North America and was the leading competitor in Western Europe and the rest of the world countries.

MARKET SEGMENTATION SUMMARY

You can view all the included markets and segmentation here:

• TURP Market
• Laser BPH Fibre Market
• Urolift Market
• Rezūm Market

RESEARCH SCOPE SUMMARY

Regions – North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year – 2021
Forecast – 2022-2028
Historical Data – 2018-2021
Quantitative Coverage – Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage – COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources – Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

WHY CHOOSE iDATA?

Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

Attention to Detail - It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

Pricing - When comparing like-with-like, iData's prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.

Work with us, and you’ll work with seasoned professionals – vigilant of deadlines, and committed to providing the most up-to-date, accurate medical device market research.